| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GSK1059615 | CTRPv2 | pan-cancer | AAC | 0.028 | 0.5 |
| mRNA | YK 4-279 | GDSC1000 | pan-cancer | AAC | 0.024 | 0.5 |
| mRNA | UNC1215 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | BRD-K63431240 | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | BX-795 | GDSC1000 | pan-cancer | AAC | 0.022 | 0.5 |
| mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | VU0155056 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | 0.035 | 0.5 |
| mRNA | lenalidomide | GDSC1000 | pan-cancer | AAC | 0.023 | 0.5 |